Proteoglycans on bone marrow endothelial cells bind and present SDF-1 towards hematopoietic progenitor cells

T. Netelenbos, J. van den Born, F. L. Kessler, S. Zweegman, P. A. Merle, J. W. van Oostveen, J. J. Zwaginga, P. C. Huijgens, A. M. Dräger

Research output: Contribution to journalArticleAcademicpeer-review

86 Citations (Scopus)


Recognition events between hematopoietic progenitor cells (HPC) and bone marrow endothelial cells (BMEC) initiate homing of HPC to the bone marrow. The chemokine SDF-1 is present on BMEC and plays a crucial role in bone marrow engraftment. We studied the role of proteoglycans (PGs) on BMEC in binding and presentation of SDF-1. SDF-1 mRNA was present in three human BMEC cell lines. Competition experiments showed that 125I-SDF-1 alpha binding to the BMEC cell line 4LHBMEC was inhibited by heparins, heparan sulfate (HS) intestinal mucosa, chondroitin and dermatan sulfate (CS/DS), but not by HS bovine kidney. Pretreatment of 4LHBMEC with glycosaminoglycan (GAG)-degrading enzymes or sodium chlorate demonstrated that SDF-1 bound to both HSPGs and CS/DSPGs in a sulfation-dependent manner, as determined with an SDF-1 antibody recognizing the CXCR4-binding site. 4LHBMEC bound four-fold more SDF-1 than HUVEC. Isolated endothelial PGs did not bind SDF-1 in a filter or microplate-binding assay, suggesting the necessity of membrane association. In flow adhesion experiments, endothelial arrest of CXCR4+ KG-1 and not of CXCR4- KG-1a cells increased significantly when SDF-1 was presented on 4LHBMEC. In conclusion, SDF-1 is produced by BMEC and binds to the BMEC cell surface via HS and CS/DS-GAGs, thereby presenting its CXCR4 binding site to HPC contributing to their arrest
Original languageEnglish
Pages (from-to)175-184
Number of pages10
Issue number1
Publication statusPublished - 1 Jan 2003


  • Bone marrow endothelial cells
  • Homing
  • Proteoglycans
  • SDF-1

Cite this